| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
89,937 |
80,979 |
$4.51M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,934 |
23,772 |
$1.25M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13,693 |
12,826 |
$1.12M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,679 |
10,975 |
$953K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
33,921 |
31,690 |
$778K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,239 |
9,752 |
$760K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
22,350 |
20,630 |
$703K |
| 92552 |
|
27,522 |
25,428 |
$600K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,889 |
5,328 |
$526K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13,531 |
12,036 |
$409K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,545 |
4,854 |
$408K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,765 |
3,454 |
$282K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,224 |
4,711 |
$252K |
| 99177 |
|
25,554 |
23,574 |
$89K |
| 87428 |
|
1,027 |
906 |
$63K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,711 |
3,551 |
$59K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,301 |
2,088 |
$48K |
| 96127 |
|
8,590 |
7,622 |
$40K |
| 96160 |
|
8,362 |
7,453 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,157 |
2,930 |
$34K |
| 99381 |
|
386 |
354 |
$32K |
| 92015 |
Determination of refractive state |
838 |
774 |
$20K |
| 83655 |
|
1,339 |
1,181 |
$15K |
| 87807 |
|
1,339 |
1,181 |
$13K |
| 99383 |
|
125 |
116 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
675 |
582 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
463 |
409 |
$8K |
| 97802 |
|
518 |
474 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
438 |
431 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
116 |
98 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
173 |
147 |
$7K |
| 85018 |
|
2,963 |
2,678 |
$7K |
| 90670 |
|
7,108 |
6,723 |
$7K |
| 3008F |
|
642 |
522 |
$6K |
| 99382 |
|
72 |
63 |
$6K |
| 36416 |
|
4,206 |
3,761 |
$6K |
| 99384 |
|
40 |
37 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
231 |
207 |
$4K |
| 94760 |
|
5,847 |
5,471 |
$3K |
| 90651 |
|
904 |
780 |
$2K |
| 90710 |
|
438 |
419 |
$2K |
| 81003 |
|
980 |
887 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
59 |
50 |
$2K |
| 90723 |
|
4,737 |
4,495 |
$1K |
| 90677 |
|
971 |
948 |
$1K |
| 90686 |
|
4,461 |
4,192 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
15 |
12 |
$1K |
| 90633 |
|
2,480 |
2,289 |
$1K |
| 90716 |
|
481 |
420 |
$953.44 |
| 90681 |
|
1,035 |
982 |
$812.80 |
| 90696 |
|
278 |
262 |
$669.37 |
| 90707 |
|
528 |
459 |
$584.79 |
| 90647 |
|
4,289 |
4,069 |
$575.32 |
| 90734 |
|
387 |
339 |
$394.41 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
60 |
45 |
$378.27 |
| 90473 |
|
16 |
16 |
$308.81 |
| 90697 |
|
150 |
141 |
$252.00 |
| 90672 |
|
181 |
143 |
$176.65 |
| 80061 |
Lipid panel |
13 |
13 |
$165.37 |
| 90715 |
|
351 |
321 |
$165.21 |
| 90661 |
|
27 |
27 |
$70.00 |
| 86308 |
|
14 |
12 |
$62.93 |
| 36415 |
Collection of venous blood by venipuncture |
18 |
14 |
$33.35 |
| 90674 |
|
87 |
84 |
$28.44 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
233 |
208 |
$10.62 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$4.98 |
| 90657 |
|
73 |
57 |
$0.00 |
| 90619 |
|
479 |
433 |
$0.00 |
| 90680 |
|
30 |
29 |
$0.00 |
| 90649 |
|
38 |
36 |
$0.00 |
| 90671 |
|
368 |
353 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
93 |
91 |
$0.00 |
| 90700 |
|
54 |
52 |
$0.00 |
| 90685 |
|
186 |
170 |
$0.00 |